{"entity":{"type":"insider","cik":"0001702626","url":"/insider/0001702626","json_url":"/insider/0001702626.json","name":"APPELROUTH STEWART","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2017-03-31","last":"2024-12-04","span_basis":"filed_date"},"name_variants":[{"name":"APPELROUTH STEWART","source":"filing","n_filings":9,"first_seen":"2018-04-30","last_seen":"2024-12-04"},{"name":"Appelrouth Stewart","source":"filing","n_filings":1,"first_seen":"2017-03-31","last_seen":"2017-03-31"}],"transactions":[{"id":2217891,"accession":"0001493152-24-048663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-048663","line_url":"/filing/0001493152-24-048663","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11112.0,"shares_display":"11,112","price_per_share":0.212,"price_display":"0.21","price_state":"stated","total_value":2355.744,"total_display":"2,355.74","total_whole":"2,356","shares_owned_after":355509.0,"shares_owned_after_display":"355,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider","n_lines":2},{"id":2159684,"accession":"0001493152-24-047092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-047092","line_url":"/filing/0001493152-24-047092#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81953.0,"shares_display":"81,953","price_per_share":0.193,"price_display":"0.19","price_state":"stated","total_value":15816.929,"total_display":"15,816.93","total_whole":"15,817","shares_owned_after":321752.0,"shares_owned_after_display":"321,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-21","scope":"insider"},{"id":2316608,"accession":"0001493152-24-010266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-010266","line_url":"/filing/0001493152-24-010266#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90910.0,"shares_display":"90,910","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":30000.3,"total_display":"30,000.30","total_whole":"30,000","shares_owned_after":239765.0,"shares_owned_after_display":"239,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider"},{"id":8264784,"accession":"0001493152-23-000212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-000212","line_url":"/filing/0001493152-23-000212#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80646.0,"shares_display":"80,646","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":25000.26,"total_display":"25,000.26","total_whole":"25,000","shares_owned_after":217063.0,"shares_owned_after_display":"217,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":4524676,"accession":"0001191434-21-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001191434-21-000001","line_url":"/filing/0001191434-21-000001#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10638.0,"shares_display":"10,638","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":24999.3,"total_display":"24,999.30","total_whole":"24,999","shares_owned_after":92538.0,"shares_owned_after_display":"92,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-25","scope":"insider"},{"id":7828236,"accession":"0001702626-19-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-19-000003","line_url":"/filing/0001702626-19-000003#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9677.0,"shares_display":"9,677","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":38998.31,"total_display":"38,998.31","total_whole":"38,998","shares_owned_after":26708.0,"shares_owned_after_display":"26,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-21","filed_date":"2019-06-25","scope":"insider"},{"id":6247854,"accession":"0001702626-18-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-18-000005","line_url":"/filing/0001702626-18-000005#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25238.0,"shares_display":"25,238","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":5552.36,"total_display":"5,552.36","total_whole":"5,552","shares_owned_after":266988.0,"shares_owned_after_display":"266,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-06","scope":"insider"},{"id":6534620,"accession":"0001702626-18-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-18-000004","line_url":"/filing/0001702626-18-000004#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126000.0,"shares_display":"126,000","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":39060.0,"total_display":"39,060.00","total_whole":"39,060","shares_owned_after":241750.0,"shares_owned_after_display":"241,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-24","scope":"insider"},{"id":6320591,"accession":"0001702626-18-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-18-000002","line_url":"/filing/0001702626-18-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"APPELROUTH STEWART","owner_display_name":"APPELROUTH STEWART","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":115750.0,"shares_owned_after_display":"115,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-27","filed_date":"2018-04-30","scope":"insider"},{"id":5262163,"accession":"0001702626-17-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-17-000002","line_url":"/filing/0001702626-17-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001702626","owner_name":"Appelrouth Stewart","owner_display_name":"Appelrouth Stewart","owner_url":"/insider/0001702626","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15750.0,"shares_display":"15,750","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":34807.5,"total_display":"34,807.50","total_whole":"34,808","shares_owned_after":15750.0,"shares_owned_after_display":"15,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2017-03-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000946644","name":"AIM ImmunoTech Inc.","url":"/issuer/0000946644","role":"Director","n_filings":10,"first_seen":"2017-03-31","last_seen":"2024-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001702626","retrieved_at":"2026-08-25T10:14:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}